Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
239.62
+2.67 (1.13%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $12.33 billion as of July 22, 2026. Its market cap has increased by 128.34% in one year.
Market Cap
12.33B
Enterprise Value
12.25B
1-Year Change
128.34%
Ranking
Category
Stock Price
$239.62
ChartMarket Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $12.33B, an increase of 7,860.48%. That is a compound annual growth rate of 50.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 12.33B | 33.92% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 13.96B |
| Madrigal Pharmaceuticals | 12.35B |
| ABIVAX Société Anonyme | 11.61B |
| BioMarin Pharmaceutical | 11.43B |
| Bio-Techne | 11.16B |
| Cytokinetics | 10.74B |
| Summit Therapeutics | 10.48B |
| Arrowhead Pharmaceuticals | 10.09B |